TY - JOUR
T1 - Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection
AU - Shornick, Laurie P.
AU - Wells, Audrey G.
AU - Zhang, Yong
AU - Patel, Anand C.
AU - Huang, Guangming
AU - Takami, Kazutaka
AU - Sosa, Moises
AU - Shukla, Nikhil A.
AU - Agapov, Eugene
AU - Holtzman, Michael J.
PY - 2008/3/1
Y1 - 2008/3/1
N2 - The epithelial surface is often proposed to actively participate in host defense, but evidence that this is the case remains circumstantial. Similarly, respiratory paramyxoviral infections are a leading cause of serious respiratory disease, but the basis for host defense against severe illness is uncertain. Here we use a common mouse paramyxovirus (Sendai virus) to show that a prominent early event in respiratory paramyxoviral infection is activation of the IFN-signaling protein Stat1 in airway epithelial cells. Furthermore, Stat1 -/- mice developed illness that resembled severe paramyxoviral respiratory infection in humans and was characterized by increased viral replication and neutrophilic inflammation in concert with overproduction of TNF-α and neutrophil chemokine CXCL2. Poor control of viral replication as well as TNF-α and CXCL2 overproduction were both mimicked by infection of Stat1-/- airway epithelial cells in culture. TNF-α drives the CXCL2 response, because it can be reversed by TNF-α blockade in vitro and in vivo. These findings pointed to an epithelial defect in Stat1-/- mice. Indeed, we next demonstrated that Stat1-/- mice that were reconstituted with wild-type bone marrow were still susceptible to infection with Sendai virus, whereas wild-type mice that received Stat1-/- bone marrow retained resistance to infection. The susceptible epithelial Stat1 -/- chimeric mice also exhibited increased viral replication as well as excessive neutrophils, CXCL2, and TNF-α in the airspace. These findings provide some of the most definitive evidence to date for the critical role of barrier epithelial cells in innate immunity to common pathogens, particularly in controlling viral replication.
AB - The epithelial surface is often proposed to actively participate in host defense, but evidence that this is the case remains circumstantial. Similarly, respiratory paramyxoviral infections are a leading cause of serious respiratory disease, but the basis for host defense against severe illness is uncertain. Here we use a common mouse paramyxovirus (Sendai virus) to show that a prominent early event in respiratory paramyxoviral infection is activation of the IFN-signaling protein Stat1 in airway epithelial cells. Furthermore, Stat1 -/- mice developed illness that resembled severe paramyxoviral respiratory infection in humans and was characterized by increased viral replication and neutrophilic inflammation in concert with overproduction of TNF-α and neutrophil chemokine CXCL2. Poor control of viral replication as well as TNF-α and CXCL2 overproduction were both mimicked by infection of Stat1-/- airway epithelial cells in culture. TNF-α drives the CXCL2 response, because it can be reversed by TNF-α blockade in vitro and in vivo. These findings pointed to an epithelial defect in Stat1-/- mice. Indeed, we next demonstrated that Stat1-/- mice that were reconstituted with wild-type bone marrow were still susceptible to infection with Sendai virus, whereas wild-type mice that received Stat1-/- bone marrow retained resistance to infection. The susceptible epithelial Stat1 -/- chimeric mice also exhibited increased viral replication as well as excessive neutrophils, CXCL2, and TNF-α in the airspace. These findings provide some of the most definitive evidence to date for the critical role of barrier epithelial cells in innate immunity to common pathogens, particularly in controlling viral replication.
UR - http://www.scopus.com/inward/record.url?scp=49149091489&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.180.5.3319
DO - 10.4049/jimmunol.180.5.3319
M3 - Article
C2 - 18292557
AN - SCOPUS:49149091489
SN - 0022-1767
VL - 180
SP - 3319
EP - 3328
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -